• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CAREFUSION ALARIS® PUMP MODULE ADMINISTRATION SET; SET, ADMINISTRATION, INTRAVASCULAR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CAREFUSION ALARIS® PUMP MODULE ADMINISTRATION SET; SET, ADMINISTRATION, INTRAVASCULAR Back to Search Results
Model Number 2420-0007
Device Problem Device Contamination with Chemical or Other Material (2944)
Patient Problem Hyperthermia (1909)
Event Date 03/23/2016
Event Type  Injury  
Manufacturer Narrative
The affected product has been received and the evaluation is pending.A follow up report will be submitted once the evaluation is completed.
 
Event Description
The customer reported that an icu patient was receiving a secondary iv of vancomycin; reportedly, at 10:30am no brown substance was observed, however when the patient arrived in pacu at 11:55 am, the nurse noticed a brown substance in the primary line and drip chamber.The patient experienced fever and elevated white blood count.Preliminary reports for blood, urine and infusion set cultures showed no growth.
 
Manufacturer Narrative
Concomitant products: green curos cap; 500ml infusion bag containing approximately 100ml of 0.9% nacl (baxter lot y005629, exp.03/17, ndc (b)(4)); 500ml infusion bag (baxter lot y005504, exp.03/17, ndc (b)(4)) containing approximately 50ml of vancomycin/nacl injection, 1.75g in ns 500ml; therapy date (b)(6) 2016.The customer¿s report of a brown substance in the tubing was confirmed.Visual inspection showed a brown flake-like substance floating within the tubing of the primary set, observed at around 31 inches from the distal end of the set and scattered in the iv liquid down to the distal end.The substance appeared somewhat water soluble because the liquid surrounding the larger concentrations of the substance in the tubing had a slight yellow/brown tinge.Ftir testing showed that the best match for this contaminant is blood.Functional testing of the primary and secondary sets showed no issues.The root cause of the contamination could not be identified.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ALARIS® PUMP MODULE ADMINISTRATION SET
Type of Device
SET, ADMINISTRATION, INTRAVASCULAR
Manufacturer (Section D)
CAREFUSION
10020 pacific mesa blvd
san diego CA 92121 4386
Manufacturer (Section G)
CAREFUSION
10020 pacific mesa blvd
san diego CA 92121 4386
Manufacturer Contact
stephen bilello
10020 pacific mesa blvd
san diego, CA 92121-4386
8586172000
MDR Report Key5595118
MDR Text Key43232620
Report Number9616066-2016-00535
Device Sequence Number1
Product Code FPA
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K944320
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,distri
Reporter Occupation Other
Type of Report Initial,Followup,Followup,Followup
Report Date 03/25/2016
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received04/21/2016
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date01/01/2019
Device Model Number2420-0007
Device Catalogue Number2420-0007
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer04/05/2016
Is the Reporter a Health Professional? No
Date Manufacturer Received07/26/2016
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured01/04/2016
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
-
-